IRIS UniCatt

Bellesi, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.237
NA - Nord America 3.160
AS - Asia 2.432
SA - Sud America 543
AF - Africa 79
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.033
SG - Singapore 1.173
DE - Germania 1.055
CN - Cina 692
SE - Svezia 510
BR - Brasile 441
IT - Italia 431
FR - Francia 234
PL - Polonia 216
GB - Regno Unito 180
FI - Finlandia 147
UA - Ucraina 121
IE - Irlanda 108
IN - India 106
VN - Vietnam 100
ID - Indonesia 81
CA - Canada 78
RU - Federazione Russa 62
JP - Giappone 42
AR - Argentina 39
MX - Messico 35
AT - Austria 29
KR - Corea 28
TR - Turchia 26
HK - Hong Kong 25
NL - Olanda 23
TW - Taiwan 22
BD - Bangladesh 21
CI - Costa d'Avorio 21
CZ - Repubblica Ceca 20
BE - Belgio 19
IQ - Iraq 17
ZA - Sudafrica 16
ES - Italia 13
IR - Iran 13
VE - Venezuela 13
EC - Ecuador 12
MA - Marocco 11
PK - Pakistan 11
CO - Colombia 10
IL - Israele 10
LT - Lituania 9
GR - Grecia 8
PY - Paraguay 8
CH - Svizzera 7
CL - Cile 7
KE - Kenya 7
SA - Arabia Saudita 7
UY - Uruguay 7
UZ - Uzbekistan 7
DZ - Algeria 6
JO - Giordania 6
MY - Malesia 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
EG - Egitto 5
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
BG - Bulgaria 4
EE - Estonia 4
HU - Ungheria 4
KG - Kirghizistan 4
RO - Romania 4
RS - Serbia 4
AL - Albania 3
DK - Danimarca 3
HN - Honduras 3
LV - Lettonia 3
NO - Norvegia 3
PH - Filippine 3
TT - Trinidad e Tobago 3
CG - Congo 2
CY - Cipro 2
ET - Etiopia 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GY - Guiana 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 9.451
Salva come PNG Salva come JPEG
Città #
Singapore 613
Chandler 482
Ashburn 304
Warsaw 198
Munich 173
Beijing 150
Fairfield 116
Dublin 105
New York 99
Hefei 94
Jacksonville 91
Rome 91
Houston 85
Los Angeles 84
San Mateo 81
Helsinki 80
Jakarta 74
Wilmington 65
Nanjing 64
Dearborn 60
Ann Arbor 58
Dallas 55
Seattle 55
Woodbridge 54
The Dalles 53
Frankfurt am Main 51
Nürnberg 50
Boston 47
Marseille 46
Milan 46
Moscow 44
Bremen 37
Cattolica 37
Lancaster 35
Chicago 34
Princeton 34
São Paulo 33
Ho Chi Minh City 31
Buffalo 30
Nanchang 29
London 28
Seoul 27
Kent 25
Nuremberg 24
Redwood City 24
Tokyo 24
Hong Kong 23
Hyderabad 23
Hanoi 22
Abidjan 21
Toronto 21
Cambridge 20
Lappeenranta 20
Lawrence 20
Montreal 20
Rio de Janeiro 19
Boardman 18
Guangzhou 18
Brno 17
Brussels 17
Hangzhou 17
Mexico City 17
Santa Clara 17
Tianjin 17
Turku 17
Leawood 16
Vienna 16
Atlanta 15
Belo Horizonte 14
Brooklyn 14
Phoenix 14
San Francisco 14
Stockholm 14
Denver 13
Düsseldorf 12
Fremont 12
Poplar 12
Amsterdam 11
Changsha 11
Izmir 11
Johannesburg 11
Manchester 11
Shanghai 11
Wroclaw 11
Kunming 10
Lauterbourg 10
Norwalk 10
Pune 10
Florence 9
Kyoto 9
Auburn Hills 8
Bexley 8
Chennai 8
Hebei 8
Paris 8
Redmond 8
Augusta 7
Baghdad 7
Brasília 7
Dhaka 7
Totale 4.861
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 400
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 318
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 313
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 257
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 241
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 216
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 213
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 207
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 196
Correlation between paraproteinaemia and viral reactivation after allo-SCT 182
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 173
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 173
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 164
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 162
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 160
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 158
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 158
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 158
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 148
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 144
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 140
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 139
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 136
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 135
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 135
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 131
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 131
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 128
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 124
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 122
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 120
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 119
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 118
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 115
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 115
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 111
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 110
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 110
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 108
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 107
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 105
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 99
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 96
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 94
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 94
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 92
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 91
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 86
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 83
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 83
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 82
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 81
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 81
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 80
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 80
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 79
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 79
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 79
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 78
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 75
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 75
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results 75
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 74
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 74
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 73
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 71
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 64
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 63
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 63
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 62
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 60
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 58
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 57
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 56
External validation of the accuracy of 'CLLflow score' 55
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 54
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 49
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 43
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 34
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 10
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 7
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements 7
Totale 9.610
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021377 0 0 0 0 0 53 41 26 44 42 143 28
2021/2022619 49 32 7 14 33 20 18 83 33 64 116 150
2022/20231.381 203 193 87 232 93 138 95 96 139 43 45 17
2023/2024738 33 181 28 41 26 100 54 54 10 29 86 96
2024/20252.019 65 61 118 101 169 108 145 92 241 185 405 329
2025/20262.317 582 156 262 504 797 16 0 0 0 0 0 0
Totale 9.610